FORA (Forian Inc. Common Stock) Stock Analysis - News
Forian Inc. Common Stock (FORA) is a publicly traded Healthcare sector company. As of May 21, 2026, FORA trades at $2.17 with a market cap of $67.79M and a P/E ratio of -13.56. FORA moved +0.46% today. Year to date, FORA is +3.33%; over the trailing twelve months it is +16.67%. Its 52-week range spans $1.64 to $4.03. Rallies surfaces FORA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in FORA news today?
Probe Targets Forian Inc.'s $2.17-Per-Share Sale to CEO-Led Consortium: Halper Sadeh LLC is investigating Forian Inc.'s $2.17-per-share going-private sale to an investor group led by CEO Max Wygod for potential fiduciary breaches and shareholder harm. The firm warns the deal terms could limit superior bids and invites shareholders to explore rights and opt for contingent-fee legal representation.
Wygod Max C bought 1.80K (~$4.91K) on Feb 13, 2025.
Wygod Max C bought 1.75K (~$4.40K) on Feb 12, 2025.
FORA Analyst Consensus
FORA analyst coverage data. Average price target: $0.00.
Common questions about FORA
What changed in FORA news today?
Probe Targets Forian Inc.'s $2.17-Per-Share Sale to CEO-Led Consortium: Halper Sadeh LLC is investigating Forian Inc.'s $2.17-per-share going-private sale to an investor group led by CEO Max Wygod for potential fiduciary breaches and shareholder harm. The firm warns the deal terms could limit superior bids and invites shareholders to explore rights and opt for contingent-fee legal representation.
Does Rallies summarize FORA news?
Yes. Rallies summarizes FORA news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is FORA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for FORA. It does not provide personalized investment advice.
